Search for Clinical Trial Results

Sponsored By

Scheie Syndrome - 32 Studies Found

Status Study
Completed Study Name: Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
Condition:
  • Mucopolysaccharidosis I
  • Hurlers Syndrome
  • Biological: rhIDU (recombinant human-Alpha-L-Iduronidase)

Recruiting Study Name: Biomarker for Patients With Hurler Disease or High-grade Suspicion for Hurler Disease
Condition:
  • Mucopolysaccharidosis Type I
  • MPS I
  • H
    Date: 2014-10-23
Recruiting Study Name: A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
Condition:
  • Mucopolysaccharidosis I
  • Hurler's Syndrome
  • Mucopolysaccharidosis I
  • Hurler Syndrome
  • Mucopolysaccharidosis I
  • Hurler's Syndrome
  • Biological: Aldurazyme Placebo
Completed Study Name: A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old
Condition:
  • Mucopolysaccharidosis I
  • Hurler Syndrome
  • Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Completed Study Name: A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease
Condition:
  • Mucopolysaccharidosis I
  • Hurler's Syndrome
  • Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Completed Study Name: A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
Condition:
  • Mucopolysaccharidosis I
  • Hurler's Syndrome
  • Cognitive Decline
  • Mucopolysaccharidosis I
  • Spinal Cord Compression
  • Mucopolysaccharidosis I
  • Date: 2008-06-17
    Interventions: Drug: laronidase 1.74 mg intrathecally every 1-3 months for 1 year
Next >>>